DP-R208

DRUG3 trials

Sponsors

Alvogen Korea

Conditions

CholesterolemiaHealthyHypertension

Phase 1

Clinical Trial to Compare the Pharmacokinetics of DP-R208

CompletedNCT02707224

Alvogen KoreaHealthy

Start: 2015-01-31End: 2015-06-30Updated: 2016-03-23

DP-R208 Pharmacokinetic Study

CompletedNCT02709187

Alvogen KoreaHealthy

Start: 2016-03-31End: 2016-05-31Updated: 2016-06-08

Phase 3

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy

CompletedNCT02770261

Alvogen KoreaCholesterolemia, Hypertension

Start: 2015-12-31End: 2016-10-31Updated: 2016-12-26

Related Papers

Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study.

2019-07-1210 citations